|
21 Jul 2011 |
BioSante Pharmaceuticals Signs Melanoma Vaccine License
|
|
20 Jul 2011 |
Dynavax Phase 3 Demonstrates Superiority and Safety of HEPLISAV(TM) vs. Engerix-B(R)
|
|
20 Jul 2011 |
Aeterna Zentaris Successfully Reached a Key Milestone in the Non-Clinical Development of its Oral Prostate Cancer Vaccine Candidate, AEZS-120
|
|
18 Jul 2011 |
Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS' HIV Vaccine VRX1273
|
|
18 Jul 2011 |
SEEK Announces Clinical Proof of Efficacy in HIV Vaccine Phase Ib/II Human Trial
|
|
18 Jul 2011 |
MEDIMMUNE SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR QUADRIVALENT SEASONAL NASAL SPRAY INFLUENZA VACCINE
|
|
18 Jul 2011 |
Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial
|
|
15 Jul 2011 |
Inovio Pharmaceuticals Demonstrates T Cell Immune Response Durability with Fourth Dose of Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
|
|
14 Jul 2011 |
Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
|
|
14 Jul 2011 |
Vical and Astellas Announce Worldwide License Agreements for TransVax(TM) Cytomegalovirus Vaccine
|
|
14 Jul 2011 |
GlaxoSmithKline and Human Genome Sciences Receive European Authorization for BENLYSTA (Belimumab)
|
|
14 Jul 2011 |
Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee in Favor of Accelerated Approval of ADCETRIS for Post-Transplant Relapsed Hodgkin Lymphoma and Relapsed or Refractory Systemic ALCL
|
|
14 Jul 2011 |
YERVOY (ipilimumab) Approved for the Treatment of Previously-Treated Advanced Melanoma in the EU
|
|
11 Jul 2011 |
Advaxis Completes Enrollment of Low Dose Cohort in CIN Study
|
|
11 Jul 2011 |
GlaxoSmithKline (GSK) Receives FDA Approval for BOOSTRIX to Help Prevent Whooping Cough in Adults 65 Years and Older
|
|
07 Jul 2011 |
Inovio Expands DNA Vaccine Intellectual Property License With the University of Pennsylvania
|
|
05 Jul 2011 |
Inovio Pharmaceuticals Synthetic DNA Vaccine Protects Against HIV in Non-Human Primates
|
|
04 Jul 2011 |
Sorrento Therapeutics' Innovative Approach to Developing Vaccines and Therapeutics for MRSA Receives Continued Support From the National Institute of Allergy and Infectious Diseases
|
|
30 Jun 2011 |
Scancell Develops New Vaccine for the Treatment of Lung Cancer
|
|
30 Jun 2011 |
Inovio Pharmaceuticals' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
|
|
30 Jun 2011 |
Medicago reports positive Phase II final results for its avian flu pandemic vaccine
|
|
29 Jun 2011 |
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
|
|
28 Jun 2011 |
VaxyGen Vaccines Ltd. Announces Exclusive Strategic Vaccine Collaboration with The Serum Institute of India (SII)
|
|
28 Jun 2011 |
Vical Provides Allovectin(R) and Herpes Simplex Vaccine Updates at BIO International Convention
|
|
28 Jun 2011 |
Diamyd Medical: Diamyd Presents Detailed Results of European Phase III Study
|
